FI20135152L - Farmaseuttinen yhdistelmäkoostumus ja menetelmiä diabeteksen ja metabolisten sairauksien hoidossa - Google Patents

Farmaseuttinen yhdistelmäkoostumus ja menetelmiä diabeteksen ja metabolisten sairauksien hoidossa Download PDF

Info

Publication number
FI20135152L
FI20135152L FI20135152A FI20135152A FI20135152L FI 20135152 L FI20135152 L FI 20135152L FI 20135152 A FI20135152 A FI 20135152A FI 20135152 A FI20135152 A FI 20135152A FI 20135152 L FI20135152 L FI 20135152L
Authority
FI
Finland
Prior art keywords
diabetes
treatment
methods
pharmaceutical combination
metabolic diseases
Prior art date
Application number
FI20135152A
Other languages
English (en)
Swedish (sv)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44899155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20135152(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130348/15A external-priority patent/RU2531048C2/ru
Priority claimed from RU2011127051/15A external-priority patent/RU2509572C2/ru
Priority claimed from PCT/IB2011/002350 external-priority patent/WO2012007845A2/en
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of FI20135152L publication Critical patent/FI20135152L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
FI20135152A 2010-07-21 2013-02-21 Farmaseuttinen yhdistelmäkoostumus ja menetelmiä diabeteksen ja metabolisten sairauksien hoidossa FI20135152L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010130348/15A RU2531048C2 (ru) 2010-07-21 2010-07-21 Лекарственное средство для уменьшения резистентности к инсулину и лечения сахарного диабета и способ повышения эффективности лечения сахарного диабета инсулином и/или гипогликемическими препаратами
RU2011127051/15A RU2509572C2 (ru) 2011-07-01 2011-07-01 Лекарственное средство для уменьшения резистентности к инсулину и для лечения сахарного диабета, способ уменьшения резистентности к инсулину, способ лечения сахарного диабета и способ лечения сахарного диабета инсулином и/или гипогликемическими препаратами
PCT/IB2011/002350 WO2012007845A2 (en) 2010-07-15 2011-07-15 A method of increasing the effect of an activated-potentiated form of an antibody

Publications (1)

Publication Number Publication Date
FI20135152L true FI20135152L (fi) 2013-02-21

Family

ID=44899155

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20135152A FI20135152L (fi) 2010-07-21 2013-02-21 Farmaseuttinen yhdistelmäkoostumus ja menetelmiä diabeteksen ja metabolisten sairauksien hoidossa

Country Status (29)

Country Link
US (1) US8617555B2 (fi)
EP (2) EP2595658A2 (fi)
JP (2) JP2013533268A (fi)
KR (2) KR20130103486A (fi)
CN (1) CN103118707A (fi)
AR (1) AR082312A1 (fi)
AU (1) AU2011281240B2 (fi)
BR (1) BR112013001299A2 (fi)
CA (1) CA2805961A1 (fi)
CL (1) CL2013000200A1 (fi)
CZ (1) CZ2013124A3 (fi)
DE (1) DE112011102396T5 (fi)
DK (1) DK201370089A (fi)
EA (1) EA029847B1 (fi)
EE (1) EE05761B1 (fi)
ES (1) ES2445846R1 (fi)
FI (1) FI20135152L (fi)
FR (1) FR2962913A1 (fi)
GB (2) GB2496799B (fi)
IT (1) ITTO20110627A1 (fi)
LT (1) LT5980B (fi)
MX (1) MX2013000804A (fi)
MY (1) MY160979A (fi)
NO (1) NO20130265A1 (fi)
NZ (1) NZ606964A (fi)
PE (1) PE20130815A1 (fi)
SE (1) SE1350212A1 (fi)
SG (1) SG187578A1 (fi)
WO (1) WO2012010966A2 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
AU2007261782A1 (en) * 2006-06-06 2007-12-27 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
NZ606767A (en) * 2010-07-15 2015-08-28 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
SE1350179A1 (sv) 2010-07-15 2013-04-12 Oleg Iliich Epshtein Farmaceutiska sammansättningar och behandlingsförfaranden
CN103124741A (zh) * 2010-07-21 2013-05-29 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及治疗眩晕、晕动病和植物神经-血管张力障碍的方法
ITTO20110638A1 (it) * 2010-07-21 2012-01-22 Oleg Iliich Epshtein Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati a patologie o stati patologici respiratori
CN103119061A (zh) 2010-07-21 2013-05-22 奥列格·伊里奇·爱泼斯坦 治疗注意力不足过动症的方法
SG10201403870XA (en) * 2010-08-06 2014-08-28 Oleg Iliich Epshtein Combination Pharmaceutical Composition And Methods Of Treating And Preventing The Infectious Diseases
TWI588153B (zh) 2012-05-18 2017-06-21 中國醫藥大學 多胜肽、編碼該多胜肽之核酸分子、以及該多胜肽之應用
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
US5811437A (en) * 1996-05-21 1998-09-22 Eli Lilly And Company Methods of increasing nitric oxide synthesis
US6150500A (en) * 1996-07-12 2000-11-21 Salerno; John C. Activators of endothelial nitric oxide synthase
WO1999026657A1 (en) * 1997-11-25 1999-06-03 Musc Foundation For Research Development Inhibitors of nitric oxide synthase
US6933272B1 (en) * 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
AU2003262804A1 (en) * 2002-08-22 2004-03-11 Nutrition 21, Inc. Arginine silicate inositol complex and use thereof
CN101107003B (zh) 2003-03-14 2012-08-08 营养学研究有限公司 用于治疗疼痛和/或炎症的顺势疗法的配剂
WO2005067928A1 (en) * 2004-01-20 2005-07-28 Astellas Pharma Inc. Method for treating erectile dysfunction
AU2007261782A1 (en) * 2006-06-06 2007-12-27 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
RU2438707C2 (ru) * 2006-06-06 2012-01-10 Олег Ильич Эпштейн Лекарственное средство для перорального лечения сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе, и способ получения твердой лекарственной формы для пероральной терапии сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе
GB0812019D0 (en) * 2008-07-02 2008-08-06 Asterion Ltd Insulin
SE1350179A1 (sv) * 2010-07-15 2013-04-12 Oleg Iliich Epshtein Farmaceutiska sammansättningar och behandlingsförfaranden
NZ606767A (en) * 2010-07-15 2015-08-28 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
EP2593474A2 (en) * 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
CN103124741A (zh) * 2010-07-21 2013-05-29 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及治疗眩晕、晕动病和植物神经-血管张力障碍的方法
ITTO20110638A1 (it) * 2010-07-21 2012-01-22 Oleg Iliich Epshtein Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati a patologie o stati patologici respiratori

Also Published As

Publication number Publication date
EP3693018A1 (en) 2020-08-12
FR2962913A1 (fr) 2012-01-27
PE20130815A1 (es) 2013-07-18
JP2013533268A (ja) 2013-08-22
WO2012010966A2 (en) 2012-01-26
US8617555B2 (en) 2013-12-31
EA201300124A1 (ru) 2013-12-30
MX2013000804A (es) 2013-10-28
CL2013000200A1 (es) 2015-01-23
EP2595658A2 (en) 2013-05-29
CN103118707A (zh) 2013-05-22
GB201707872D0 (en) 2017-06-28
KR20180127515A (ko) 2018-11-28
DE112011102396T5 (de) 2013-05-02
AR082312A1 (es) 2012-11-28
EA029847B1 (ru) 2018-05-31
CZ2013124A3 (cs) 2013-06-12
KR20130103486A (ko) 2013-09-23
ES2445846R1 (es) 2015-01-02
ES2445846A2 (es) 2014-03-05
NO20130265A1 (no) 2013-04-18
GB2496799B (en) 2017-11-22
GB2552405A (en) 2018-01-24
SE1350212A1 (sv) 2013-04-22
NZ606964A (en) 2015-08-28
US20130064824A1 (en) 2013-03-14
GB2552405B (en) 2018-05-30
MY160979A (en) 2017-03-31
BR112013001299A2 (pt) 2017-11-21
AU2011281240A1 (en) 2013-03-07
EE201300007A (et) 2013-08-15
GB201302924D0 (en) 2013-04-03
ITTO20110627A1 (it) 2012-01-22
CA2805961A1 (en) 2012-01-26
JP2016222684A (ja) 2016-12-28
AU2011281240B2 (en) 2016-07-07
DK201370089A (en) 2013-02-19
LT5980B (lt) 2013-12-27
SG187578A1 (en) 2013-03-28
WO2012010966A3 (en) 2012-03-29
LT2013018A (lt) 2013-10-25
GB2496799A (en) 2013-05-22
EE05761B1 (et) 2016-03-15

Similar Documents

Publication Publication Date Title
FI20135152L (fi) Farmaseuttinen yhdistelmäkoostumus ja menetelmiä diabeteksen ja metabolisten sairauksien hoidossa
ZA201505849B (en) Composition of novel carbohydrate drug for treatment of human diseases
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
IL236221A (en) History of theophyridone and pharmacological preparations containing them for the treatment of diseases
IL239735B (en) A pharmaceutical preparation for the treatment of diseases related to toxic aldehyde
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
CO6880066A2 (es) Composición farmacéutica de sabor enmascarado
EP2564845A4 (en) MEDICINE FOR TREATING HYPERPLASIC AND INFLAMMATORY DISORDERS IN HUMANS BASED ON DIINDOLYLMETHANE
EP3628326C0 (en) METHODS AND SUBSTANCES FOR TREATING PUMP DISEASE
DK2652652T3 (da) Medikmentadministration
ZA201304822B (en) Azetidine derivatives useful for the treatment of metabolic and inflimmatory diseases
IL254446A0 (en) Implantable drug delivery preparations and treatment methods thereof
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
SMT201500005B (it) Composizione framaceutica inalabile
IL232434A0 (en) Medicine for medical treatment and/or improvement of sepsis
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
FI20125888A (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
EP2751137A4 (en) MOLECULAR GENETIC APPROACH FOR THE TREATMENT AND DIAGNOSIS OF ALCOHOL DEPENDENCE AND PHARMACODEPPENDANCE
EP2402342A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING TYPE 2 DIABETES
IT1403064B1 (it) Composizione di sostanze per il trattamento di pazienti con ipercolesterolemia e patologie collegate
HK1157189A1 (en) Pharmaceutical composition for the treatment of tumor diseases
TH0901004644A (th) สารประกอบสไปโร-ออกซินดอล และการใช้สารเป็นยารักษาโรค
FI20135145L (fi) Farmaseuttinen yhdistelmäkoostumus ja menetelmiä kardiovaskulaariseen systeemiin liittyvien tautien tai tilojen hoitamiseksi

Legal Events

Date Code Title Description
FD Application lapsed